share_log

British American Tobacco | 6-K: British American Tobacco p.l.c. Transaction In Own Shares

British American Tobacco | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

英美煙草 | 6-K:外國發行人報告
SEC announcement ·  03/26 06:09
Moomoo AI 已提取核心訊息
British American Tobacco (BAT), a leading multinational tobacco company, has filed a Form 6-K with the United States Securities and Exchange Commission (SEC) on March 26, 2024. The filing, which is a requirement for foreign private issuers in the US, includes a press release titled 'Transaction in own shares' dated the same day. The report was signed by Nancy Jiang, Senior Assistant Company Secretary of BAT. The document indicates that BAT has engaged in a transaction involving its own shares, details of which were published and made available by the company. The address of BAT's principal executive office is Globe House, 4 Temple Place, London, United Kingdom.
British American Tobacco (BAT), a leading multinational tobacco company, has filed a Form 6-K with the United States Securities and Exchange Commission (SEC) on March 26, 2024. The filing, which is a requirement for foreign private issuers in the US, includes a press release titled 'Transaction in own shares' dated the same day. The report was signed by Nancy Jiang, Senior Assistant Company Secretary of BAT. The document indicates that BAT has engaged in a transaction involving its own shares, details of which were published and made available by the company. The address of BAT's principal executive office is Globe House, 4 Temple Place, London, United Kingdom.
領先的跨國菸草公司英美菸草公司(BAT)已於2024年3月26日向美國證券交易委員會(SEC)提交了6-K表格。該文件是美國外國私人發行人的要求,其中包括當天發佈的題爲 “自有股票交易” 的新聞稿。該報告由英美菸草公司高級助理秘書南希·江(Nancy Jiang)簽署。該文件表明,英美菸草公司進行了一項涉及自有股票的交易,該交易的細節已由該公司公佈和提供。英美菸草公司主要行政辦公室的地址是英國倫敦聖殿廣場4號環球大廈。
領先的跨國菸草公司英美菸草公司(BAT)已於2024年3月26日向美國證券交易委員會(SEC)提交了6-K表格。該文件是美國外國私人發行人的要求,其中包括當天發佈的題爲 “自有股票交易” 的新聞稿。該報告由英美菸草公司高級助理秘書南希·江(Nancy Jiang)簽署。該文件表明,英美菸草公司進行了一項涉及自有股票的交易,該交易的細節已由該公司公佈和提供。英美菸草公司主要行政辦公室的地址是英國倫敦聖殿廣場4號環球大廈。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息